KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Cash & Equivalents (2016 - 2025)

Labcorp Holdings' Cash & Equivalents history spans 17 years, with the latest figure at $532.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 64.95% year-over-year to $532.3 million; the TTM value through Dec 2025 reached $532.3 million, down 64.95%, while the annual FY2025 figure was $532.3 million, 64.95% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $532.3 million at Labcorp Holdings, down from $598.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.0 billion in Q3 2021 and bottomed at $99.3 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $687.6 million (2023), against an average of $976.6 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 484.3% in 2021 before it crashed 86.27% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.5 billion in 2021, then plummeted by 78.23% to $320.6 million in 2022, then surged by 67.44% to $536.8 million in 2023, then surged by 182.92% to $1.5 billion in 2024, then tumbled by 64.95% to $532.3 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Cash & Equivalents are $532.3 million (Q4 2025), $598.1 million (Q3 2025), and $647.3 million (Q2 2025).